Dr. Haleh Hamedifar born in 1972 in Tehran, IRAN.
Graduated as top student from Tehran University of Medical Sciences (TUMS) in 1995. MBA from Linkoping University, Sweden in 2011.
Former advisor of WHO regarding GMP & Quality Assurance of Vaccine and Biopharmaceuticals.
Joined CinnaGen Co. as QA consultant in 1998, and became CEO from 2001. Based on her background in pharmacy focused to change the strategy of company from diagnostic field to biopharmaceutical.
She managed several biosimilar projects which their products are now in national as well as regional market. At this time CinnaGen Group is the biggest biopharmaceutical manufacturer in region for both its production capacity as well as number of products in the market.
She is founder of CinnaGen Group as well as CinnaGen’s 7 daughter companies.